Astec LifeSciences Limited

NSE:ASTEC.NS

1079.85 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income -469.295349.4731,211.258890.709613.525559.041557.116287.431-191.64147.75486.51659.51513.65548.984132.124103.7579.451
Depreciation & Amortization 362.534336.525343.563256.553231.642193.494146.815136.819138.484126.873147.672118.74286.37958.341.63932.6679.493
Deferred Income Tax 0-50.333-306.748-235.454-162.869-176.013-32.29217.597000000000
Stock Based Compensation 3.0113.3071.0470.0990.5551.6353.3865.6536.65600000000
Change In Working Capital 104.936-59.062-1,101.025-1,033.196878.266-545.43363.726-375.864-218.778-230.892-138.855-80.882-63.78841.597-113.241-217.14351.421
Accounts Receivables -135.3221,215.989-836.832-301.723-343.753-15.571-107.514-216.226-229.844-534.369112.561-306.38900000
Inventory 989.103-1,087.968-808.549150.791-283.211-143.712-202.05256.99-135.48546.59-259.321-2.717-135.375-35.94-41.967-102.22210.183
Accounts Payables -888.041-142.75607.15-700.5331,311.525-355.497417.946-85.067151.10100000000
Other Working Capital 139.196-44.333-62.794-181.731193.705-30.653265.778-432.854-83.293-277.482120.466-78.16571.58777.537-71.274-114.92141.238
Other Non Cash Items 633.668166.65187.94639.666123.287120.131-92.005120.681217.881122.08882.85266.93850.23215.02744.33256.78343.167
Operating Cash Flow -127.485746.561236.041-81.6231,684.406152.855646.746192.317-54.053165.824178.185164.31386.478163.908104.854-23.943183.532
Investing Activities:
Investments In Property Plant And Equipment -1,354.981-1,172.591-1,039.783-1,025.278-452.94-527.754-496.957-208.885-259.251-201.076-190.39-259.921-468.026-357.14-226.267-27.661-4.05
Acquisitions Net 3.5967.7671.2390.0481.5750.16103.935000000000
Purchases Of Investments -2.765-1.1020-0.324-1.575-1.027000-0.4720000-256.36600
Sales Maturities Of Investments 000-0.0481.098-0.1612.21624.1276.05200.442124.1240177.539000
Other Investing Activites 3.16739.75-0.115294.507-286.2643.7895.3257.80319.2979.3743.1332.494-32.10411.29-106.17-5.4290
Investing Cash Flow -1,354.15-1,125.074-1,038.659-731.095-738.106-524.992-489.416-176.955-233.902-192.174-186.815-133.303-500.13-168.311-588.803-33.09-4.05
Financing Activities:
Debt Repayment -1,010.24-427-920.267-883.502-783.073-527.293-42.594-77.751-48.126-49.162-74.795-120.045-23.246-4.514000
Common Stock Issued 0.791.3092.996.732.1962.761.9821.965010012.36828.43313.6075.00200
Common Stock Repurchased 0425.691-920.267-883.502783.073-527.29300087.4375.21986.687260.0260000
Dividends Paid -29.409-29.406-29.378-29.356-35.363-35.345-35.2350-29.298-21.678-21.678-9.838-9.838-19.806-8.274-5.5160
Other Financing Activities 500407.1092,671.6972,602.992-912.1761,458.12-149.19766.381386.491-14.76410.82-5.891183.57340.805424.86657.725-49.637
Financing Cash Flow 1,481.616377.703804.775813.362-945.343370.949-182.45-9.405309.067101.8261.934-20.654424.11516.485491.59452.209-49.637
Other Information:
Effect Of Forex Changes On Cash 0-0.0010-0.3370.001-0.0010-0.001-5.181-00.001-0.001000.0010-115.725
Net Change In Cash 19.12-0.8112.1570.3070.958-1.189-25.125.95615.93175.476-6.69510.35510.46312.0827.646-4.82414.12
Cash At End Of Period 24.3244.7345.5453.3883.0812.1233.31228.43222.925120.244.72451.41941.06430.60118.51910.87324.993